FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2256178229> ?p ?o ?g. }

• W2256178229 abstract "Activating mutations in KRAS are prevalent in lung cancer and have been causally linked to the oncogenic process. However, therapies targeted to oncogenic RAS have been ineffective to date and identification of KRAS targets that impinge on the oncogenic phenotype is warranted. Based on published studies showing that mitotic kinases Aurora A (AURKA) and B (AURKB) cooperate with oncogenic RAS to promote malignant transformation and that AURKA phosphorylates RAS effector pathway components, the aim of this study was to investigate whether AURKA and AURKB are KRAS targets in lung cancer and whether targeting these kinases might be therapeutically beneficial. In order to determine whether oncogenic KRAS induces Aurora kinase expression, we used qPCR and western blotting in three different lung cell-based models of gain- or loss-of-function of KRAS. In order to determine the functional role of these kinases in KRAS-induced transformation, we generated KRAS-positive A549 and H358 cells with stable and inducible shRNA-mediated knockdown of AURKA or AURKB and evaluated transformation in vitro and tumor growth in vivo. In order to validate AURKA and/or AURKB as therapeutically relevant KRAS targets in lung cancer, we treated A549 and H358 cells, as well as two different lung cell based models of gain-of-function of KRAS with a dual Aurora kinase inhibitor and performed functional in vitro assays. We determined that KRAS positively regulates AURKA and AURKB expression. Furthermore, in KRAS-positive H358 and A549 cell lines, inducible knockdown of AURKA or AURKB, as well as treatment with a dual AURKA/AURKB inhibitor, decreased growth, viability, proliferation, transformation, and induced apoptosis in vitro. In addition, inducible shRNA-mediated knockdown of AURKA in A549 cells decreased tumor growth in vivo. More importantly, dual pharmacological inhibiton of AURKA and AURKB reduced growth, viability, transformation, and induced apoptosis in vitro in an oncogenic KRAS-dependent manner, indicating that Aurora kinase inhibition therapy can specifically target KRAS-transformed cells. Our results support our hypothesis that Aurora kinases are important KRAS targets in lung cancer and suggest Aurora kinase inhibition as a novel approach for KRAS-induced lung cancer therapy." @default.
• W2256178229 created "2016-06-24" @default.
• W2256178229 creator A5003239045 @default.
• W2256178229 creator A5028495282 @default.
• W2256178229 creator A5059245767 @default.
• W2256178229 creator A5061507902 @default.
• W2256178229 creator A5074322188 @default.
• W2256178229 date "2016-02-03" @default.
• W2256178229 modified "2023-10-17" @default.
• W2256178229 title "Aurora kinase targeting in lung cancer reduces KRAS-induced transformation" @default.
• W2256178229 cites W1629666474 @default.
• W2256178229 cites W1657157395 @default.
• W2256178229 cites W1696210500 @default.
• W2256178229 cites W1775578030 @default.
• W2256178229 cites W1844062608 @default.
• W2256178229 cites W1844282257 @default.
• W2256178229 cites W1869384610 @default.
• W2256178229 cites W1965488058 @default.
• W2256178229 cites W1968925807 @default.
• W2256178229 cites W1970527559 @default.
• W2256178229 cites W1975592015 @default.
• W2256178229 cites W1976046338 @default.
• W2256178229 cites W1981427365 @default.
• W2256178229 cites W1990317973 @default.
• W2256178229 cites W1990428670 @default.
• W2256178229 cites W1996356041 @default.
• W2256178229 cites W1999851814 @default.
• W2256178229 cites W2000361062 @default.
• W2256178229 cites W2006019980 @default.
• W2256178229 cites W2009774619 @default.
• W2256178229 cites W2013722663 @default.
• W2256178229 cites W2021929133 @default.
• W2256178229 cites W2022920832 @default.
• W2256178229 cites W2027741380 @default.
• W2256178229 cites W2028014658 @default.
• W2256178229 cites W2028999918 @default.
• W2256178229 cites W2030698208 @default.
• W2256178229 cites W2031188674 @default.
• W2256178229 cites W2031523460 @default.
• W2256178229 cites W2037211670 @default.
• W2256178229 cites W2039248250 @default.
• W2256178229 cites W2042783729 @default.
• W2256178229 cites W2046553897 @default.
• W2256178229 cites W2049341882 @default.
• W2256178229 cites W2051603299 @default.
• W2256178229 cites W2054260164 @default.
• W2256178229 cites W2061175622 @default.
• W2256178229 cites W2062831570 @default.
• W2256178229 cites W2067115862 @default.
• W2256178229 cites W2070787022 @default.
• W2256178229 cites W2073265198 @default.
• W2256178229 cites W2075667512 @default.
• W2256178229 cites W2081363393 @default.
• W2256178229 cites W2081990599 @default.
• W2256178229 cites W2096170327 @default.
• W2256178229 cites W2097152766 @default.
• W2256178229 cites W2098517908 @default.
• W2256178229 cites W2100469448 @default.
• W2256178229 cites W2104323199 @default.
• W2256178229 cites W2112146471 @default.
• W2256178229 cites W2115945897 @default.
• W2256178229 cites W2117471298 @default.
• W2256178229 cites W2123641389 @default.
• W2256178229 cites W2123723651 @default.
• W2256178229 cites W2124801766 @default.
• W2256178229 cites W2128553601 @default.
• W2256178229 cites W2130746121 @default.
• W2256178229 cites W2134296571 @default.
• W2256178229 cites W2136940817 @default.
• W2256178229 cites W2137478129 @default.
• W2256178229 cites W2140334822 @default.
• W2256178229 cites W2140557275 @default.
• W2256178229 cites W2140609626 @default.
• W2256178229 cites W2140760855 @default.
• W2256178229 cites W2152517276 @default.
• W2256178229 cites W2157153074 @default.
• W2256178229 cites W2165435278 @default.
• W2256178229 cites W2170552969 @default.
• W2256178229 doi "https://doi.org/10.1186/s12943-016-0494-6" @default.
• W2256178229 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4739397" @default.
• W2256178229 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26842935" @default.
• W2256178229 hasPublicationYear "2016" @default.
• W2256178229 type Work @default.
• W2256178229 sameAs 2256178229 @default.
• W2256178229 citedByCount "33" @default.
• W2256178229 countsByYear W22561782292016 @default.
• W2256178229 countsByYear W22561782292017 @default.
• W2256178229 countsByYear W22561782292018 @default.
• W2256178229 countsByYear W22561782292019 @default.
• W2256178229 countsByYear W22561782292020 @default.
• W2256178229 countsByYear W22561782292021 @default.
• W2256178229 countsByYear W22561782292022 @default.
• W2256178229 countsByYear W22561782292023 @default.
• W2256178229 crossrefType "journal-article" @default.
• W2256178229 hasAuthorship W2256178229A5003239045 @default.
• W2256178229 hasAuthorship W2256178229A5028495282 @default.
• W2256178229 hasAuthorship W2256178229A5059245767 @default.
• W2256178229 hasAuthorship W2256178229A5061507902 @default.
• W2256178229 hasAuthorship W2256178229A5074322188 @default.
• W2256178229 hasBestOaLocation W22561782291 @default.

• next